Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Alternatives International (NAII) Common Equity (2016 - 2025)

Natural Alternatives International's Common Equity history spans 15 years, with the latest figure at $67.0 million for Q4 2025.

  • On a quarterly basis, Common Equity fell 15.28% to $67.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $67.0 million, a 15.28% decrease, with the full-year FY2025 number at $68.4 million, down 17.15% from a year prior.
  • Common Equity hit $67.0 million in Q4 2025 for Natural Alternatives International, down from $69.0 million in the prior quarter.
  • Over the last five years, Common Equity for NAII hit a ceiling of $89.9 million in Q3 2022 and a floor of $67.0 million in Q4 2025.
  • Historically, Common Equity has averaged $81.7 million across 5 years, with a median of $84.2 million in 2021.
  • Biggest five-year swings in Common Equity: increased 18.8% in 2021 and later fell 17.15% in 2025.
  • Tracing NAII's Common Equity over 5 years: stood at $84.4 million in 2021, then increased by 6.08% to $89.5 million in 2022, then dropped by 4.55% to $85.5 million in 2023, then decreased by 7.39% to $79.1 million in 2024, then dropped by 15.28% to $67.0 million in 2025.
  • Business Quant data shows Common Equity for NAII at $67.0 million in Q4 2025, $69.0 million in Q3 2025, and $68.4 million in Q2 2025.